Gene expression profiling is a way of monitoring the activity (or expression) of thousands of genes at the same time in order to provide a comprehensive picture of cellular function. These profiles, for example, might reveal which cells are actively dividing or how the cells respond to a given therapy. Many of these techniques assess the complete genome or all the genes in a single cell at the same time.The relative quantity of mRNA expressed in two or more experimental conditions is frequently measured in expression profiling research. Variable levels of a certain mRNA sequence suggest a changing necessity for the protein for which the mRNA codes, indicating either a pathogenic state or a homeostatic reaction.
Gene expression has developed as a crucial technique in a variety of applications, including drug discovery and development, clinical diagnostics, biotechnology, microbiology, and others. This approach is becoming more popular at various phases of the drug development process. The constraints on the utilisation of present technologies and the growing variety of applications for gene expression research have pushed the development of new approaches.
Western blotting, northern blotting, enzyme-linked immunosorbent assays, PCR technology with an emphasis on quantitative PCR, differential protein display, and DNA sequencing and hybridization arrays technology with an emphasis on macro arrays and microarrays in facilitating gene expression are a few examples of gene expression technological advancements.
The segmentation coverage of the study is provided below.
Gene Expression Analysis Market based on End User:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
Gene Expression Analysis Market based on Product:
- Consumable
- Instruments
- Type
- Polymerase Chain Reaction
- Next Generation Sequencing
- DNA Microarrays
- Others
Gene Expression Analysis Market based on Application:
- Drug Discovery
- Diagnostics
Gene Expression Analysis Market based on Geography:
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
The report includes competitive analyses and profiles of the industry’s major players, including Illumina Inc., Agilent Technologies, Thermo Fisher Scientific Inc., PerkinElmer Inc., Oxford Nanopore Technologies, QIAGEN, Bio-Rad Laboratories Inc., PacBio, Promega Corporation, and F. Hoffmann-La Roche Ltd. To increase the gene expression market’s product portfolio, major companies have used product introduction, product growth, and acquisition as significant development tactics.
Personalised medicine is concerned with personalising medical treatments to individual individuals based on their genetic composition. The measurement of gene expression is critical in discovering particular biomarkers linked with illnesses, treatment responses, and prognosis. Researchers can find gene signatures that correspond with disease subtypes or predict therapy results by analysing gene expression patterns. The need for broad gene expression research to uncover and verify biomarkers is driven by the desire for personalised treatment.
Technology improvements such as next-generation sequencing (NGS), microarray technologies, and single-cell analysis boost the gene expression industry. These technical developments have boosted gene expression analysis’s throughput, sensitivity, and accuracy, making it more accessible and cheap.
As the need for personalised treatment develops, so does the demand for sophisticated gene expression analysis methods and platforms, propelling the gene expression market forward.
Grants and funding possibilities are provided by government funding agencies and organisations to assist scientific research, including gene expression investigations. Researchers and institutions may now invest in gene expression analysis thanks to increased government assistance in the form of research grants and financing programmes. This financing allows for the improvement of knowledge in the subject, as well as the creation of new technologies and the study of fresh applications. It allows researchers to undertake gene expression studies and propels the gene expression industry forward. Government assistance in the form of expedited regulatory processes and guidelines builds trust and opens the path for the commercialization and widespread acceptance of gene expression technology and products.
- This report illustrates the most vital attributes of the Gene Expression Analysis Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Gene Expression Analysis Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Gene Expression Analysis Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Gene Expression Analysis Market.
List of Tables
TABLE 1. GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 2. GENE EXPRESSION ANALYSIS MARKET VALUE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. GENE EXPRESSION ANALYSIS MARKET VALUE FOR ACADEMIC AND RESEARCH INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. GENE EXPRESSION ANALYSIS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 6. GENE EXPRESSION ANALYSIS MARKET VALUE FOR CONSUMABLE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. GENE EXPRESSION ANALYSIS MARKET VALUE FOR INSTRUMENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 9. GENE EXPRESSION ANALYSIS MARKET VALUE FOR DRUG DISCOVERY , BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. GENE EXPRESSION ANALYSIS MARKET VALUE FOR DIAGNOSTICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 15. U.S GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 16. U.S GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 17. U.S GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 18. CANADA GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 19. CANADA GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 20. CANADA GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 21. MEXICO GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 22. MEXICO GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 23. MEXICO GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 24. EUROPE GENE EXPRESSION ANALYSIS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 25. EUROPE GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 26. EUROPE GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 27. EUROPE GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 28. GERMANY GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 29. GERMANY GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 30. GERMANY GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 31. U.K GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 32. U.K GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 33. U.K GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 34. FRANCE GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 35. FRANCE GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 36. FRANCE GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 37. ITALY GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 38. ITALY GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 39. ITALY GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 40. SPAIN GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 41. SPAIN GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 42. SPAIN GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 43. ROE GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 44. ROE GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 45. ROE GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 46. ASIA PACIFIC GENE EXPRESSION ANALYSIS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 47. ASIA PACIFIC GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 48. ASIA PACIFIC GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 49. ASIA PACIFIC GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 50. CHINA GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 51. CHINA GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 52. CHINA GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 53. INDIA GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 54. INDIA GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 55. INDIA GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 56. JAPAN GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 57. JAPAN GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 58. JAPAN GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 59. REST OF APAC GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 60. REST OF APAC GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 61. REST OF APAC GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 62. LATIN AMERICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 63. LATIN AMERICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 64. LATIN AMERICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 65. BRAZIL GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 66. BRAZIL GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 67. BRAZIL GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 68. ARGENTINA GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 69. ARGENTINA GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 70. ARGENTINA GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 71. MIDDLE EAST AND AFRICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 72. MIDDLE EAST AND AFRICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 73. MIDDLE EAST AND AFRICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 74. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 75. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 76. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 77. UAE GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 78. UAE GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 79. UAE GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 80. REST OF MIDDLE EAST AND AFRICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 81. REST OF MIDDLE EAST AND AFRICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 82. REST OF MIDDLE EAST AND AFRICA GENE EXPRESSION ANALYSIS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 83. QIAGEN : FINANCIALS
TABLE 84. QIAGEN : PRODUCTS & SERVICES
TABLE 85. QIAGEN : RECENT DEVELOPMENTS
TABLE 86. F. HOFFMANN-LA ROCHE LTD.: FINANCIALS
TABLE 87. F. HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES
TABLE 88. F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS
TABLE 89. PERKINELMER INC.: FINANCIALS
TABLE 90. PERKINELMER INC.: PRODUCTS & SERVICES
TABLE 91. PERKINELMER INC.: RECENT DEVELOPMENTS
TABLE 92. BIO-RAD LABORATORIES, INC.: FINANCIALS
TABLE 93. BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES
TABLE 94. BIO-RAD LABORATORIES, INC.: RECENT DEVELOPMENTS
TABLE 95. PROMEGA CORPORATION: FINANCIALS
TABLE 96. PROMEGA CORPORATION: PRODUCTS & SERVICES
TABLE 97. PROMEGA CORPORATION: RECENT DEVELOPMENTS
TABLE 98. PACBIO: FINANCIALS
TABLE 99. PACBIO: PRODUCTS & SERVICES
TABLE 100. PACBIO: RECENT DEVELOPMENTS
TABLE 101. ILLUMINA INC. : FINANCIALS
TABLE 102. ILLUMINA INC. : PRODUCTS & SERVICES
TABLE 103. ILLUMINA INC. : DEVELOPMENTS
TABLE 104. AGILENT TECHNOLOGIES INC.: FINANCIALS
TABLE 105. AGILENT TECHNOLOGIES INC.: PRODUCTS & SERVICES
TABLE 106. AGILENT TECHNOLOGIES INC.: RECENT DEVELOPMENTS
TABLE 107. THERMO FISHER SCIENTIFIC INC.: FINANCIALS
TABLE 108. THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES
TABLE 109. THERMO FISHER SCIENTIFIC INC.: RECENT DEVELOPMENTS
TABLE 110. OXFORD NANOPORE TECHNOLOGIES: FINANCIALS
TABLE 111. OXFORD NANOPORE TECHNOLOGIES: PRODUCTS & SERVICES
TABLE 112. OXFORD NANOPORE TECHNOLOGIES: RECENT DEVELOPMENTS
